Physician profile
Grace Chang
NPI 1841039054
$1,136.82
in general payments reported to CMS, 2019-2025
8 companies · $1,137 in 2025
The $1,137 reported for 2025 was more than what 88% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $1,137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,136.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $558.17 | 2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Lilly USA, LLC | $196.20 | 2025 | Kisunla, Amyvid, Zepbound |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $108.24 | 2025 | Caplyta |
| Genentech USA, INC. | $72.61 | 2025 | Ocrevus Zunovo |
| Vanda Pharmaceuticals INC. | $72.47 | 2025 | Hetlioz, Fanapt |
| Lundbeck LLC | $57.64 | 2025 | Vyepti |
| Axsome Therapeutics, INC. | $44.04 | 2025 | Symbravo, Auvelity |
| Acadia Pharmaceuticals INC | $27.45 | 2025 | Nuplazid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grace Chang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.